Deep brain stimulation and behavioural changes: Is comedication the most important factor?

Neurodegenerative Diseases

Volumn 9, Issue 1, 2011, Pages 18-24

  Lulé, Dorothée ^a,b   Heimrath, Johanna ^a   Pinkhardt, Elmar H ^a   Ludolph, Albert C ^a   Uttner, Ingo ^a   Kassubek, Jan ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Deep brain stimulation; Dopamine dysregulation syndrome; Executive function; Gambling; Parkinson's disease

Indexed keywords

AMANTADINE; APOMORPHINE; CABERGOLINE; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DRUG DOSE COMPARISON; DRUG EFFECT; FEMALE; HIGH RISK BEHAVIOR; HUMAN; IMPULSE CONTROL DISORDER; IMPULSIVENESS; MALE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; POLYPHARMACY; PRIORITY JOURNAL; TASK PERFORMANCE;

AGED; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; FEMALE; GAMBLING; HUMANS; IMPULSIVE BEHAVIOR; LEVODOPA; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; RISK-TAKING; SUBTHALAMIC NUCLEUS;

EID: 82455208851     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000328817     Document Type: Article

References (37)

1. Deuschl G: Neurostimulation for Parkinson disease. JAMA 2009; 301: 104-105.
2. Houeto JL, Mallet L, Mesnage V, Tezenas du Montcel S, Béhar C, Gargiulo M, Torny F, Pelissolo A, Welter ML, Agid Y: Subthalamic stimulation in Parkinson disease: behavior and social adaptation. Arch Neurol 2006; 63: 1090-1095. (Pubitemid 44232314)
3. Saß H, Wittchen H-U, Zaudig M: Diagnostisches und Statistisches Manual Psychischer Störungen (DSM-IV-TR): Textrevision. Göttingen, Hogrefe, 2003.
4. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V: Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009; 24: 1461-1467.
5. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB: Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006; 63: 969-973. (Pubitemid 44036299)
6. Voon V, Hassan K, Zurowski M, Duff-Canning S, de Souza M, Fox S, Lang AE, Miyasaki J: Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006; 66: 1750-1752. (Pubitemid 43964638)
7. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J: Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006; 67: 1254-1257. (Pubitemid 44563838)
8. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE: Impulse control disorders in Parkinson disease: a cross-sectional study of 3,090 patients. Arch Neurol 2010; 67: 589-595.
9. Abler B, Hahlbrock R, Unrath A, Grön G, Kassubek J: At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists. Brain 2009; 132: 2396-2402.
10. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog E: Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005; 62: 1-5.
11. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag S: Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. Analysis of published case series. Mov Disord 2007; 22: 1757-1763. (Pubitemid 47597599)
12. Voon V, Thomsen T, Miyasaki JM, et al: Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007; 64: 212-216.
13. Wolters EC, van der Werf YD, van den Heuvel OA: Parkinson's disease-related disorders in the impulsive-compulsive spectrum. J Neurol 2008; 255: 48-56.
14. Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE: Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 2009; 84: 310-316.
15. Driver-Dunckley E, Noble BN, Hentz JG, et al: Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007; 30: 249-255. (Pubitemid 47511504)
16. Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M, Caporali A, Mancini F, Pezzoli G, Ceravolo R, Bonuccelli U, Barone P: Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease. Mov Disord 2011; 26: 464-468.
17. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI: Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588. (Pubitemid 43867425)
18. Daniele A, Albanese A, Contarino MF, Zinzi P, Barbier A, Gasparini F, Romito LM, Bentivoglio AR, Scerrati M: Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 175-182. (Pubitemid 36160676)
19. Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, Albanese A: Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 248-252. (Pubitemid 46579660)
20. Hälbig TD, Tse W, Frisina PG, Baker BR, Hollander E, Shapiro H, Tagliati M, Koller WC, Olanow CW: Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol 2009; 16: 493-497.
21. Lu C, Bharmal A, Suchowersky O: Gambling and Parkinson disease. Arch Neurol 2006; 63: 298.
22. Guridi J, Rodriguez-Oroz MC, Lozano AM, Moro E, Albanese A, Nuttin B, Gybels J, Ramos E, Obeso JA: Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. Neurology 2000; 55: 21-28.
23. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE: Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653.
24. Lopiano L, Torre E, Benedetti F, et al: Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. Eur Neurol 2003; 50: 94-99. (Pubitemid 37116970)
25. Kalbe E, Calabrese P, Kohn N, Hilker R, Riedel O, Wittchen HU, Dodel R, Otto J, Ebersbach G, Kessler J: Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 2008; 14: 93-101. (Pubitemid 351726305)
26. Oswald W, Fleischmann U: Nürnberger-Alters- Inventar (NAI), ed 4. Göttingen, Hogrefe, 1999.
27. Schmidt K-H, Metzler P: WST-Wortschatztest. Diagnostica 1994; 40: 293-297.
28. Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986; 5: 165-173. (Pubitemid 17221439)
29. Bechara A, Damásio AR, Damásio H, Anderson SW: Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50: 7-15.
30. Bechara A, Tranel D, Damasio H: Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 2000; 123: 2189-2202.
31. Frank MJ: Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Netw 2006; 19: 1120-1136. (Pubitemid 44466333)
32. Frank MJ, Samanta J, Moustafa AA, Sherman SJ: Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318: 1309-1312. (Pubitemid 350172897)
33. Alegret M, Junque C, Valldeoriola F, et al: Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol 2001; 58: 1223-1227. (Pubitemid 32751741)
34. Smeding HM, Goudriaan AE, Foncke EM, Schuurman PR, Speelman JD, Schmand B: Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry 2007; 78: 517-519. (Pubitemid 46662902)
35. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE: Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123: 2091-2108.
36. Schroeder U, Kuehler A, Hennenlotter A, Haslinger B, Tronnier VM, Krause M, Pfister R, Sprengelmeyer R, Lange KW, Ceballos- Baumann AO: Facial expression recognition and subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2004; 75: 648-650. (Pubitemid 38406672)
37. Houeto JL, Mesnage V, Mallet L, Pillon B, Gargiulo M, du Moncel ST, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y: Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72: 701-707. (Pubitemid 34557009)